Medicare
On Aug. 2, the Centers for Medicare & Medicaid Services issued its fiscal year (FY) 2020 final rule for the inpatient and long-term care hospital prospective payment systems (PPS). This advisory covers the rule’s LTCH-related provisions. AHA issued a separate Regulatory Advisory on the…
The Centers for Medicare & Medicaid Services July 29 issued a proposed rule that would update physician fee schedule payments for calendar year (CY) 2020.
This supplemental report updates a previous analysis to reflect the revised Medicare-X Choice legislation as introduced in April, 2019.
Medicare will cover nationally Chimeric Antigen Receptor T-cell therapies approved by the Food and Drug Administration to treat certain cancers, as well as off-label uses recommended by compendia approved by the Centers for Medicare & Medicaid Services.
Offering a government insurance program reimbursing at Medicare rates as a public option on the health insurance exchanges could place as many as 55% of rural hospitals.
On July 11, the Centers for Medicare & Medicaid Services issued its calendar year 2020 proposed rule for the home health prospective payment system.
Medicare fee-for-service providers can sign up to participate in a pilot program allow clinicians to access a patient’s Medicare claims data for treatment purposes without logging into a separate application.
The Centers for Medicare & Medicaid Services yesterday projected that the average basic premium for a Medicare Part D prescription drug plan will decline from $32.50 in 2019 to $30 in 2020.
Medicare Administrative Contractors should begin accepting modifier codes for appropriate use criteria on Medicare claims for advanced diagnostic imaging on Jan. 1.
The AHA, AAMC and FAH agree with the Committee’s goal of reducing the price of drugs, and applaud many of the steps outlined in the description of the Chairman’s Mark of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. However, have serious concerns regarding the provisions that…